CNKSR2
protein-codingconnector enhancer of kinase suppressor of Ras 2, the group of PDZ domain containing|Sterile alpha motif domain containing|Pleckstrin homology domain containing
Gene summary
This gene encodes a multidomain protein that functions as a scaffold protein to mediate the mitogen-activated protein kinase pathways downstream from Ras. This gene product is induced by vitamin D and inhibits apoptosis in certain cancer cells. It may also play a role in ternary complex assembly of synaptic proteins at the postsynaptic membrane and coupling of signal transduction to membrane/cytoskeletal remodeling. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~281.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0100148
Submitter: ClinGen
CNKSR2 was first reported in relation to X-linked complex neurodevelopmental disorder in 2012 (Houge et al. 2012, PMID:22511892). Affected males commonly present with delayed psychomotor development, limited or absent speech, childhood -onset and sleep-related seizures, cognitive deterioration, attention issues, and hyperactivity. Carrier females may be unaffected or mildly affected. To date, at least 17 unique variants predicted to cause loss of function of the protein have been described. In addition to SNVs and indels, whole-gene deletions and intragenic CNVs have also been identified in affected individuals. This gene is intolerant to loss-of function variants (pLI = 1, LOEUF = 0.18, gnomAD v2.1.1). This gene-disease relationship is further supported by expression studies and rescue experiments. In summary, CNKSR2 is definitively associated with X-linked complex neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Working Group on 12/16/2020 (SOP Version 8).
Inheritance Pattern: XL
Disease ID:MONDO:0030909
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0018614
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0030909
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0019181
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CNKSR2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014927.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 23 | 31 | 2 | 56 | ||
| missense | 3 | 225 | 13 | 1 | 242 | |
| nonsense | 15 | 9 | 11 | 35 | ||
| start loss | 0 | |||||
| frameshift | 14 | 9 | 2 | 25 | ||
| splice donor/acceptor (+/-2bp) | 5 | 7 | 24 | 36 | ||
| Total | 34 | 28 | 285 | 44 | 3 | 394 |
Highest pathogenic variant AF is 9.650926e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055742.2 | 22 | MANE Select | |
| Ensembl | ENSP00000368824.3 | 22 | MANE Select | |
| RefSeq | NP_001162118.1 | 21 | Standard | |
| RefSeq | NP_001162119.1 | 21 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- EGF-Ncore
- MAP2K and MAPK activation
- Disease
- Signal Transduction
- RAF/MAP kinase cascade
Biological Process
- regulation of signal transduction
- postsynapse organization
Molecular Function
- protein binding
- identical protein binding
Cellular Component
- cytoplasm
- neuron projection
- neuronal cell body
- extracellular exosome
- glutamatergic synapse
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000379510
- Coding exons
- 22
- Length
- 280278
- Individuals with no LoFs
- 123921
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 2
- Defined
- 123925
- p
- 0.0000161
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.61 | 177 | 373 | 0.475 | 0.0000275 | 6793 |
| Missense (PolyPhen) | 26 | 99.306 | 0.26182 | 1781 | ||
| Synonymous | 1.52 | 114 | 137 | 0.835 | 0.0000101 | 1923 |
| Loss of Function | 5.57 | 3 | 41.9 | 0.0717 | 0.00000346 | 714 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000040 | 0.000030 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000027 | 0.000018 | rare |
| South Asian | 0.000058 | 0.000034 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May function as an adapter protein or regulator of Ras signaling pathways. {ECO:0000269|PubMed:14597674}.;
- Disease
- DISEASE: Mental retardation, X-linked, syndromic, Houge type (MRXSHG) [MIM:301008]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSHG is characterized by delayed development, intellectual disability, speech and language delay, and early-onset seizures. Carrier females may be mildly affected. {ECO:0000269|PubMed:25223753, ECO:0000269|PubMed:28098945}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- LoFtool
- 0.369
- RVIS EVS
- -0.47
- RVIS percentile EVS
- 23.25
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.973
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |